Table 1 Characteristics of treatment successes and double treatment failures
Baseline characteristic | Success (N=115) | Double Failure (N=22) | All (N=137) | P-value |
|---|---|---|---|---|
Sex | ||||
Female | 76 (66%) | 16 (73%) | 92 (67%) | 0.72 |
Male | 39 (34%) | 6 (27%) | 45 (33%) | |
Age (years) | ||||
Mean (SD) | 41 (15) | 35 (17) | 40 (15) | 0.14 |
Median (Q1, Q3) | 39 (30, 53) | 29 (23, 46) | 37 (26, 53) | |
Laterality | ||||
Unilateral | 10 (8.7%) | 3 (14%) | 13 (9.5%) | 0.44 |
Bilateral | 105 (91%) | 19 (86%) | 124 (91%) | |
Anatomic location | ||||
Anterior/Intermediate | 18 (26%) | 10 (46%) | 28 (20%) | 0.003 |
Posterior/Panuveitis | 97 (74%) | 12 (55%) | 109 (80%) | |
CME | ||||
No | 85 (74%) | 10 (46%) | 95 (69%) | 0.016 |
Yes | 30 (26%) | 12 (55%) | 42 (31%) | |
Retinal vasculitis | ||||
No | 58 (50%) | 4 (18%) | 62 (45%) | 0.006 |
Yes | 9 (7.8%) | 5 (23%) | 14 (10%) | |
FA not done | 48 (42%) | 13 (59%) | 61 (45%) | |
Uveitis duration (months) | ||||
Mean (SD) | 25 (52) | 31 (52) | 26 (52) | 0.63 |
Median (Q1, Q3) | 3.2 (0.63, 25) | 7.9 (3.5, 27) | 3.8 (0.64, 26) | |
Missing | 1 (0.9%) | 1 (4.5%) | 2 (1.5%) | |
Country | ||||
Australia | 8 (7.0%) | 4 (18%) | 12 (8.8%) | 0.18 |
India | 77 (67%) | 12 (55%) | 89 (65%) | |
Saudi Arabia | 7 (6.1%) | 0 (0%) | 7 (5.1%) | |
US/Mexico | 23 (20%) | 6 (27%) | 29 (21%) | |
Study site | ||||
Coimbatore | 21 (18%) | 4 (18%) | 25 (18%) | 0.18 |
Madurai | 35 (30%) | 6 (27%) | 41 (30%) | |
Melbourne | 8 (7.0%) | 4 (18%) | 12 (8.8%) | |
Mexico | 1 (0.9%) | 0 (0%) | 1 (0.7%) | |
Pondicherry | 21 (18%) | 2 (9.1%) | 23 (17%) | |
Portland | 5 (4.3%) | 4 (18%) | 9 (6.6%) | |
Riyadh | 7 (6.1%) | 0 (0%) | 7 (5.1%) | |
San Francisco | 17 (15%) | 2 (9.1%) | 19 (14%) | |